The treatment of children suffering from chronic myelogenous leukemia: A comparison of the result of treatment with imatinib mesylate and allogeneic hematopoietic stem cell transplantation

Author:

Hamidieh Amir Ali1,Ansari Shahla2,Darbandi Bahram2,Soroush Alborz3,Arjmandi Rafsanjani Khadijeh2,Alimoghaddam Kamran1,Bahosh Gholamreza2,Behfar Maryam1,Ghavamzadeh Ardeshir1

Affiliation:

1. Hematology-Oncology and Stem Cell Transplantation Research Center; Tehran University of Medical Sciences; Tehran; Iran

2. Department of Pediatric Hematology-Oncology; Ali Asgar Children's Hospital; Tehran University of Medical Sciences; Tehran; Iran

3. Department of Pharmacy; Faculty of pharmacy; Tehran University of Medical Sciences; Tehran; Iran

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Reference44 articles.

1. Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage;Fialkow;Am J Med,1977

2. Clonal origin of chronic myelocytic leukemia in man;Fialkow;Proc Natl Acad Sci USA,1967

3. Efficacy and pharmacokinetics of imatinib mesylate in a child with chronic myeloid leukemia;Sugawara;Rinsho Ketsueki,2003

4. Chronic leukemias of childhood;Altman;Pediatr Clin North Am,1988

5. Chronic myelogenous leukemia: A review;Cortes;Am J Med,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3